Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Volha Lenskaya"
Filter
Filter
Article category
Publication year
Authors
Review Article
Article image
Gene fusions in melanocytic lesions: an updated comprehensive review
Volha Lenskaya, Larisa Erikson, Victor G. Prieto, Woo Cheal Cho
J Pathol Transl Med. 2026;60(3):285-306.   Published online May 8, 2026
DOI: https://doi.org/10.4132/jptm.2026.03.11
  • 8,188 View
  • 255 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary Material
The scope of gene fusions in melanocytic neoplasms is broader than previously recognized, extending well beyond the Spitz-lineage neoplasms where kinase fusions involving ALK, ROS1, NTRK1/2/3, RET, MET, BRAF, and MAP3K8 define biologically and morphologically distinct tumors. Emerging studies demonstrate that a meaningful proportion of conventional non-Spitz lineage melanomas harbor oncogenic fusions. Such fusions may impact clinical behavior, histopathologic presentation and provide opportunities for targeted therapy. The World Health Organization classification of skin tumors, 5th edition, now incorporates fusion status into taxonomy and risk stratification, yet some important questions remain for further investigation: fusion-associated neoplasms can mimic non-melanocytic neoplasm; Spitz-type fusions appear in non-Spitz lesions; and melanocytic differentiation may occur in some other fusion-driven lesions. Broad-panel next-generation sequencing (including RNAseq), together with targeted fluorescence in situ hybridization and immunohistochemistry enhances detection of known and novel fusion partners. Early clinical evidence of TRK, ALK, and ROS1 inhibitor efficacy underscores the translational promise of fusion testing and opens avenues for personalized therapy. This review synthesizes current knowledge on the genomics, histopathology, diagnosis, and therapeutic implications of fusion-driven melanocytic neoplasms, highlighting consensus points and remaining controversies.

Citations

Citations to this article as recorded by  
  • Clinicopathologic and molecular characteristics of acral melanomas harboring RARA fusions
    Mokhtar H. Abdelhammed, Richard K. Yang, Volha Lenskaya, Carlos A. Torres-Cabala, Woo Cheal Cho
    Human Pathology.2026; 177: 106211.     CrossRef
  • Targeted ALK inhibition achieving tumour control in metastatic melanoma: a case report
    Cornelia Schuster, Irja Alida Oppedal , Liv Iren Vinnem, Eirin Lunden Abrahamsson, Torill Myklestad Barrett, Eli Sihn Samdal Steinskog, Hege Elisabeth Giercksky Russnes , Ã…slaug Helland
    Acta Oncologica.2026; 65: 814.     CrossRef
  • Molecular Diagnosis of Melanocytic Neoplasia: Updates and Challenges
    Jaclyn M. Plotzke, Grace Wang, Scott C. Bresler, Paul W. Harms
    Cancers.2026; 18(20): 3330.     CrossRef
  • Melanoma of the Scalp Harboring a Novel AGFG1::ERBB4 Fusion: A Case Report With Clinicopathologic and Genomic Characterization
    Xu Cao, Hong Yu, Kenneth L. Muldrew, Rachael M. Johnson, Li Liang, Ying Pei, Yve T. Huttenbach, C. Cameron Yin, Songlin Zhang
    Genes, Chromosomes and Cancer.2026;[Epub]     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP